[go: up one dir, main page]

ZA969147B - Application of the gax protein to the treatment of cancer - Google Patents

Application of the gax protein to the treatment of cancer

Info

Publication number
ZA969147B
ZA969147B ZA969147A ZA969147A ZA969147B ZA 969147 B ZA969147 B ZA 969147B ZA 969147 A ZA969147 A ZA 969147A ZA 969147 A ZA969147 A ZA 969147A ZA 969147 B ZA969147 B ZA 969147B
Authority
ZA
South Africa
Prior art keywords
cancer
treatment
application
gax protein
gax
Prior art date
Application number
ZA969147A
Inventor
Didier Branellec
Patrice Denefle
Aude Leroux
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA969147B publication Critical patent/ZA969147B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA969147A 1995-10-31 1996-10-30 Application of the gax protein to the treatment of cancer ZA969147B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512871A FR2740344B1 (en) 1995-10-31 1995-10-31 APPLICATION OF PROTEIN GAX TO THE TREATMENT OF CANCERS

Publications (1)

Publication Number Publication Date
ZA969147B true ZA969147B (en) 1997-05-27

Family

ID=9484112

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969147A ZA969147B (en) 1995-10-31 1996-10-30 Application of the gax protein to the treatment of cancer

Country Status (13)

Country Link
EP (1) EP0858466A1 (en)
JP (1) JPH11514881A (en)
KR (1) KR19990067174A (en)
AU (1) AU730324B2 (en)
BR (1) BR9611206A (en)
CA (1) CA2233250A1 (en)
CZ (1) CZ131598A3 (en)
FR (1) FR2740344B1 (en)
HU (1) HUP9900011A3 (en)
NO (1) NO981822L (en)
SK (1) SK56198A3 (en)
WO (1) WO1997016459A1 (en)
ZA (1) ZA969147B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754822B1 (en) * 1996-10-18 1998-11-27 Rhone Poulenc Rorer Sa POLYPEPTIDES COMPRISING PROTEIN GAS DOMAINS, INVOLVED IN TRANSCRIPTION REPRESSION AND / OR INTERACTING WITH OTHER PROTEINS, CORRESPONDING NUCLEIC ACIDS AND USES THEREOF
AU2001289652A1 (en) * 2000-06-28 2002-01-08 Aventis Pharma S.A. Compositions and methods for regulating the cell cycle using a ki gene or polypeptide
BRPI0906946A2 (en) 2008-01-09 2015-07-14 Univ Konkuk Ind Coop Corp Baculovirus-based vaccines
KR101230913B1 (en) 2009-11-06 2013-02-07 중앙대학교 산학협력단 Nanoparticle-Based Gene Delivery Systems
KR101232123B1 (en) 2010-10-08 2013-02-12 연세대학교 산학협력단 Gene Delivery Systems Exhibiting Enhanced Tumor-Specific Expression with Recombinant Expression Control Sequence
JP5969044B2 (en) 2011-11-24 2016-08-10 バイロメッド カンパニー リミテッド Adenovirus-producing new cell line and its use
KR101429696B1 (en) 2012-11-21 2014-08-13 국립암센터 Recombinant adenovirus with enhanced safety and anti-cancer activity and use thereof
WO2017065497A1 (en) 2015-10-12 2017-04-20 한양대학교 산학협력단 Adenovirus complex for gene transfer and gene therapy
SG11202005509YA (en) 2017-12-13 2020-07-29 Genemedicine Co Ltd Recombinant adenoviruses and stem cells comprising same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705361B1 (en) * 1993-05-18 1995-08-04 Centre Nat Rech Scient Viral vectors and use in gene therapy.
US5856121A (en) * 1994-02-24 1999-01-05 Case Western Reserve University Growth arrest homebox gene
FR2732357B1 (en) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa VIRAL VECTORS AND USE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS, ESPECIALLY RESTENOSIS

Also Published As

Publication number Publication date
NO981822D0 (en) 1998-04-23
EP0858466A1 (en) 1998-08-19
FR2740344A1 (en) 1997-04-30
KR19990067174A (en) 1999-08-16
BR9611206A (en) 1999-03-30
CA2233250A1 (en) 1997-05-09
NO981822L (en) 1998-04-23
FR2740344B1 (en) 1997-11-21
WO1997016459A1 (en) 1997-05-09
AU7498296A (en) 1997-05-22
HUP9900011A3 (en) 1999-11-29
CZ131598A3 (en) 1998-08-12
AU730324B2 (en) 2001-03-01
SK56198A3 (en) 1998-11-04
HUP9900011A2 (en) 1999-04-28
JPH11514881A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
ZA96740B (en) Skin treatment composition
GB9310241D0 (en) Cosmetic treatment of substrates
HU9603369D0 (en) Treatment of vegetables
AUPM761094A0 (en) Treatment of hides
ZA969147B (en) Application of the gax protein to the treatment of cancer
PL336760A1 (en) Treatment of skin diseases
AU2265695A (en) The use of sertraline to treat cancer patients
AU7565894A (en) Acupuncture treatment of common baldness
AU6829696A (en) Treatment of solutions
AU4417996A (en) Treatment of prostate cancer
AU6171196A (en) Therapeutic uses of ta99
GB9400600D0 (en) Treatment of motion seckness
GB2331014B (en) Therapeutic uses of glucan
GB9504444D0 (en) Treatment of eczema
AU3247995A (en) Treatment of hides
EP0705104A4 (en) Method of cancer treatment
AUPO955497A0 (en) Treatment of cancer
GB9503200D0 (en) Methods of treatment
AU2375297A (en) Treatment of hides
AUPO598197A0 (en) Treatment of hides
GB9507482D0 (en) Skin treatment composition
GB9717401D0 (en) Treatment of psoriasis
GB9710054D0 (en) Treatment of diseases
GB9226032D0 (en) Treatment of cancer
GB9503143D0 (en) Treatment of depression